You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 6, 2025

Drugs Containing Excipient (Inactive Ingredient) CARBOMER HOMOPOLYMER TYPE A


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing CARBOMER HOMOPOLYMER TYPE A excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing CARBOMER HOMOPOLYMER TYPE A excipient

Carbomer Homopolymer Type A: Market Dynamics and Financial Trajectory

What is Carbomer Homopolymer Type A?

Carbomer Homopolymer Type A is a high molecular weight polymer compound widely used in the cosmetic and pharmaceutical industries. It is known for its ability to absorb large amounts of water, increasing in volume up to 1,000 times to form stable gels and thick solutions[2].

Market Size and Growth Projections

The global carbomer market, which includes Carbomer Homopolymer Type A, has been experiencing significant growth. As of 2023, the global carbomer market size was valued at approximately $758.9 million and is projected to grow to $1,281.6 million by 2032 at a compound annual growth rate (CAGR) of 5.8%[4].

Regional Market Dominance

The Asia Pacific region dominates the carbomer market, holding around 40.28% of the market share in 2023. China plays a crucial role in this dominance due to its large population and increasing disposable income, which drives the demand for personal care products[4][5].

North American Market

North America is the largest consumer of cosmetic and personal care products globally. The increasing awareness regarding personal hygiene and wellbeing in this region is expected to drive the growth of the carbomer market significantly during the forecast period[5].

Market Segments

Type Segmentation

The carbomer market is segmented into different types, including Carbomer 940, 980, 934, and others. Carbomer 940 is expected to hold a significant share due to its excellent thickening, high viscosity, and higher suspending performance, making it a preferred rheology modifier in personal care and cosmetic products[4].

Application Segmentation

Carbomer Homopolymer Type A is used in various applications:

Personal Care & Cosmetics

It is commonly found in toothpaste, gels, shampoo, skin lotions, and lubricant eye drops due to its thickening and stabilizing properties[2].

Pharmaceutical Industry

In the pharmaceutical sector, carbomers are used as rheology modifiers, suspension stabilizers, tablet binders, mucoadhesive aids, and bioavailability enhancers. They are particularly useful in drug delivery gel systems and are suitable for ophthalmology, oral, nasal, intestinal, rectal, and vaginal product applications[4].

Market Drivers

Growing Demand from Pharmaceutical Industry

The increasing adoption of carbomers in the pharmaceutical industry, driven by the need for controlled-release medicines and advanced drug formulations, is a significant driver of market growth. The rising health consciousness and infrastructure development in the healthcare sector also contribute to this trend[4].

Increasing Use in Personal Care Products

The growing demand for rheology modifiers in cosmetic and personal care products, such as hair gels, body baths, lotions, and moisturizers, is another key driver. The increasing awareness of personal hygiene and wellbeing, especially in North America, further boosts this segment[5].

Market Restraints

Government Regulations

Government regulations, particularly those imposed by the FDA, restrict the use of benzene polymerized carbomers due to their carcinogenic properties. This has led manufacturers to switch to alternative methods, increasing production costs and potentially hampering market growth[4].

Financial Trajectory

Current Market Value

As of 2023, the global carbomer market was valued at $758.9 million. It is projected to grow to $805.5 million in 2024 and reach $1,281.6 million by 2032[4].

Compound Annual Growth Rate (CAGR)

The market is expected to grow at a CAGR of 5.8% from 2024 to 2032, indicating a steady and significant expansion over the forecast period[4].

Regional Growth

The U.S. carbomer market is expected to grow significantly, reaching an estimated value of $249.8 million by 2032, driven by the growing demand from the personal care industry[4].

Key Trends and Opportunities

Sustainable Packaging

There is an increasing focus on sustainable packaging to reduce plastic usage, which could impact the carbomer market as companies look for eco-friendly alternatives[3].

Mergers and Acquisitions

Concentration on mergers and acquisitions to fortify market standing is a trend that could influence the carbomer market, especially in the pharmaceutical excipients sector[3].

Use of Artificial Intelligence

The utilization of artificial intelligence to monitor and enhance supply chain transparency, as well as to optimize production processes, is another trend that could benefit the carbomer market[3].

Conclusion

The Carbomer Homopolymer Type A market is poised for significant growth driven by its versatile applications in the pharmaceutical and personal care industries. Despite regulatory challenges, the market is expected to expand steadily, driven by increasing demand for advanced drug formulations and personal care products.

Key Takeaways

  • Market Growth: The global carbomer market is projected to grow from $758.9 million in 2023 to $1,281.6 million by 2032 at a CAGR of 5.8%.
  • Regional Dominance: Asia Pacific, particularly China, dominates the market, while North America is a significant consumer of cosmetic and personal care products.
  • Application Segmentation: Carbomer Homopolymer Type A is widely used in personal care, cosmetics, and pharmaceutical applications.
  • Market Drivers: Growing demand from the pharmaceutical industry and increasing use in personal care products are key drivers.
  • Market Restraints: Government regulations on benzene polymerized carbomers are a significant restraint.

FAQs

What is Carbomer Homopolymer Type A used for?

Carbomer Homopolymer Type A is used in various applications, including personal care products like toothpaste, gels, shampoo, and skin lotions, as well as in pharmaceuticals as rheology modifiers, suspension stabilizers, and bioavailability enhancers[2].

What are the key drivers of the carbomer market?

The key drivers include the growing demand from the pharmaceutical industry for controlled-release medicines and advanced drug formulations, and the increasing use in personal care products due to rising health consciousness and awareness of personal hygiene[4][5].

What are the main restraints on the carbomer market?

Government regulations restricting the use of benzene polymerized carbomers due to their carcinogenic properties are a significant restraint, leading to increased production costs and potential market growth hampering[4].

Which region dominates the carbomer market?

The Asia Pacific region, particularly China, dominates the carbomer market due to its large population and increasing disposable income driving the demand for personal care products[4][5].

What is the projected CAGR for the carbomer market from 2024 to 2032?

The market is expected to grow at a CAGR of 5.8% from 2024 to 2032[4].

Sources

  1. Market Research Intellect: Carbomer Homopolymer Market Size, Scope And Forecast Report.
  2. Drugs.com: Carbomer Homopolymer Type A: What is it and where is it used?
  3. Research and Markets: Pharmaceutical Excipients Global Market Report 2024.
  4. Fortune Business Insights: Carbomer Market Size, Share, Growth | Global Forecast [2032].
  5. SkyQuestT: Carbomer Market Analysis, Size, Share & Trends | 2031.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.